Benitec Biopharma

BNTC · NASDAQ

$9.04+$0.68 (+8.13%)TodayMarket closed ·
Prev close $8.36

Who owns BNTC

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 76.2% of BNTC’s shares.

  • Montanova Capital, LLC33.6%
  • Janus Henderson Investors7.2%
  • Franklin Advisers, Inc.7.0%
  • Adage Capital Management, L.P.6.2%
  • Next 6 largest institutions22.2%
  • All other shareholders23.8%
Top institutional holders of BNTC
HolderShares% of shares
Montanova Capital, LLC11.55M33.62%
Janus Henderson Investors2.48M7.22%
Franklin Advisers, Inc.2.41M7.02%
Adage Capital Management, L.P.2.12M6.17%
RA Capital Management, LP1.85M5.39%
Nantahala Capital Management, LLC1.49M4.33%
BlackRock Institutional Trust Company, N.A.1.27M3.71%
HBM Partners AG1.04M3.03%
Simplify Asset Management Inc1.01M2.93%
Vanguard Capital Management, LLC954.53K2.78%

Largest mutual fund holders

Top mutual fund holders of BNTC
HolderShares% of shares
Simplify Health Care ETF1.06M3.08%
Franklin Templeton Investment Funds -Biotechnology Discovery997.48K2.90%
Franklin Biotechnology Discovery Fund995.15K2.90%
Vanguard Total Stock Market Index Fund649.54K1.89%
iShares Russell 2000 ETF531.18K1.55%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of BNTC in the last 6 months.

Latest BNTC insider transactions
InsiderTypeSharesValue
Friedman David MatthewAward35.00K—

Short interest

Settled Sep 30, 2026

Shares short
2.04M
Days to cover
10.19
% of shares outstanding
5.94%
Average daily volume
200.15K
Change since last report
−6.7%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.